HDAC9 and neuroblastoma: Treatment with the HDAC inhibitor vorinostat (SAHA) also induced neuroblastoma cell apoptosis and increased chemotherapy sensitivity [50, 51] and demonstrated synergistic efficacy with both radiation and retinoic acid [50, 96, 97], demonstrating the clinical potential of vorinostat for the treatment of neuroblastoma.